U.S. prosecutors go after SAC hedge fund for insider trading

U.S. prosecutors have filed their biggest-ever case of insider trading. The allegation: SAC Capital Advisors, a hedge fund, got early warning about the failure of an Alzheimer's drug in clinical trials. That info let the fund sell its holdings in the companies behind the drug, and reap $276 million.
E-Mail Newsroom


Comments

Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • HTML tags will be transformed to conform to HTML standards.

More information about formatting options

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.